This is the authors' abstract. We don't add key points for this paper.
A series of new quinazolinone derivatives have been synthesized. Elemental analysis, IR, 1H NMR and mass spectral data elucidated the structures of all newly synthesized compounds. In vitro antimicrobial activities of the synthesized compounds were investigated against Gram-positive Bacillus subtilis (ATCC No. 6633), Staphylococcus aureus (ATCC No. 25923), Gram-negative Salmonella typhimurium (ATCC No. 23564), Pseudomonas aeruginosa (ATCC No. 27853) and fungi Candida albicans and Aspergillus niger. Among all the tested compounds, some of the tested compounds showed equipotent activity with standard.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mandhane et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: